43 related articles for article (PubMed ID: 5704785)
1. The role of CYP enzymes in cocaine-induced liver damage.
Pasanen M; Pellinen P; Stenbäck F; Juvonen RO; Raunio H; Pelkonen O
Arch Toxicol; 1995; 69(5):287-90. PubMed ID: 7654131
[TBL] [Abstract][Full Text] [Related]
2. [Formation of chloroform from carbon tetrachloride in liver microsomes, lipid peroxidation and destruction of cytochrome P-450].
Reiner O; Athanassopoulos S; Hellmer KH; Murray RE; Uehleke H
Arch Toxikol; 1972; 29(3):219-33. PubMed ID: 4404917
[No Abstract] [Full Text] [Related]
3. The role of theliver in drug metabolism.
Remmer H
Am J Med; 1970 Nov; 49():617-29. PubMed ID: 4924589
[No Abstract] [Full Text] [Related]
4. Mechanisms of cell injury with hepatotoxic chemicals.
Farber JL; Gerson RJ
Pharmacol Rev; 1984 Jun; 36(2 Suppl):71S-75S. PubMed ID: 6382357
[No Abstract] [Full Text] [Related]
5. [Altered biotransformation of phenazone, aminophenazone and codeine as evidence of early injury to rat liver after administration of carbon tetrachloride].
Klinger W; Neugebauer A; Splinter FK
Arch Toxikol; 1968; 23(3):178-85. PubMed ID: 5704785
[No Abstract] [Full Text] [Related]
6. [Studies of the mechanism of enzyme induction. XIV. Effect of age on the activity and inducibility of phenazone hydroxylases, aminophenazone-N-demethylase, codeine-O-demethylase and nitroreductase of the rat liver].
Klinger W; Kusch T; Neugebauer A; Splinter FK; Ankermann H
Acta Biol Med Ger; 1968; 21(3):257-69. PubMed ID: 5750773
[No Abstract] [Full Text] [Related]
7. [Kinetic investigation on the enzymatic hydroxylation of phenazone, oxidative O-demethylation of codeine and N-demethylation of aminophenazone by rat liver microsomes].
Neugebauer A; Splinter FK; Häfke D; Kober R; Schirlitz H; Klinger W
Biochem Pharmacol; 1969 Jul; 18(7):1559-76. PubMed ID: 4308802
[No Abstract] [Full Text] [Related]
8. Biphasic effect of pyrazolone derivatives on drug-metabolizing enzyme in rat liver.
Bien E; Gebert I; Skorka G
Pharmazie; 1985 Jun; 40(6):412-4. PubMed ID: 3875867
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of dimeylaminophenazone, 4-aminophenazone and phenazone in rats of various ages].
Klinger W
Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):309-22. PubMed ID: 5348404
[No Abstract] [Full Text] [Related]
10. [Significance of the liver for the biological activity of drugs].
Ackermann E
Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):3-8. PubMed ID: 5501425
[No Abstract] [Full Text] [Related]
11. The estimation of antipyrine in biological materials.
BRODIE BB; AXELROD J
J Biol Chem; 1949 May; 179(1):25-9. PubMed ID: 18119216
[No Abstract] [Full Text] [Related]
12. The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material.
BRODIE BB; AXELROD J
J Pharmacol Exp Ther; 1950 Jun; 99(2):171-84. PubMed ID: 15437290
[No Abstract] [Full Text] [Related]
13. Factors influencing induction of hepatic microsomal drug-metabolizing enzymes.
KATO R; CHIESARA E; VASSANELLI P
Biochem Pharmacol; 1962 Mar; 11():211-20. PubMed ID: 14454283
[No Abstract] [Full Text] [Related]
14. THE EFFECT OF CODEINE TOLERANCE ON HEPATIC MICROSOMAL DRUG METABOLISM IN THE RAT.
JOHANNESSON T; ROGERS LA; FOUTS JR; WOODS LA
Acta Pharmacol Toxicol (Copenh); 1965; 22():107-11. PubMed ID: 14284186
[No Abstract] [Full Text] [Related]
15. THE STABILITY OF THE DRUG METABOLISING ENZYMES OF LIVER MICROSOMAL PREPARATIONS.
LEADBEATER L; DAVIES DR
Biochem Pharmacol; 1964 Dec; 13():1607-17. PubMed ID: 14248389
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
